MISEX Fees and Costs — Midas Special Opportunities

Data updated: 2026-08-18

The net expense ratio is 3.44%: a 0.93% management fee, a 0.25% 12b-1 fee plus 2.26% other expenses. This share class carries a redemption fee of 1.00%. In fiscal 2025 the fund paid $272 in broker commissions, 0.0013% of average net assets, and portfolio turnover was 5%.

MISEX Fees and Expenses

Annual operating expenses and sales charges of MISEX. Prospectus, as of December 31, 2025.

Annual operating expenses
Management fee0.93%
12b-1 fee0.25%
Other expenses2.26%
Gross expense ratio3.44%
Fee waiver—
Net expense ratio3.44%
Sales charges
Max front load0.00%
Max deferred load0.00%
Redemption fee1.00%
Expense limitation in place (N-CEN)No
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

MISEX Costs Over Time

On $10,000 invested in MISEX, assuming 5% a year before costs, total costs come to $2,050 over 5 years, cutting the return by 3.61% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 3.44%)$361$1,099$1,857
Trading costs (broker commissions)$0$0$1
Lost growth on money paid in costs$0$55$193
Total costs$361$1,154$2,050
Value after costs$10,139$10,422$10,713
Impact on return, per year3.61%3.61%3.61%

MISEX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): 0.0013%
  • Total broker commissions: $272
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 5%
  • Securities lending: none during the year

MISEX Agency Brokers

Commissions paid.

BrokerAmountShare
WELLINGTON SHIELDS & CO LLC$272100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.